enVVeno Medical (NASDAQ:NVNO) Stock Rating Lowered by Wall Street Zen

enVVeno Medical (NASDAQ:NVNO) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Sunday, Wall Street Zen reports.

Several other equities research analysts have also commented on the company. LADENBURG THALM/SH SH upgraded enVVeno Medical from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of enVVeno Medical in a research note on Friday, September 25th. Finally, Zacks Research upgraded enVVeno Medical to a “hold” rating in a report on Tuesday, July 7th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold”.

enVVeno Medical Trading Up 2.1%

Shares of NASDAQ:NVNO opened at $6.87 on Friday. The firm has a market cap of $4.74 million, a price-to-earnings ratio of -0.36 and a beta of 1.29. The stock’s 50-day moving average price is $8.89 and its two-hundred day moving average price is $10.30. enVVeno Medical has a 12-month low of $6.52 and a 12-month high of $25.90.

enVVeno Medical (NASDAQ:NVNO) last released its quarterly earnings data on Thursday, October 29th. The company reported ($6.29) EPS for the quarter, missing analysts’ consensus estimates of ($3.27) by ($3.02). As a group, research analysts forecast that enVVeno Medical will post -16.19 earnings per share for the current fiscal year.

enVVeno Medical Company Profile

enVVeno Medical Corporation (NASDAQ:NVNO) is a late-stage medical device company focused on developing bioprosthetic, or tissue-based, treatments for venous disease. Its primary focus is chronic venous insufficiency, a condition in which damaged or absent valves allow blood to flow backward in the veins and can cause swelling, pain, skin changes and ulcers.

The company’s lead product is the VenoValve, a surgically implanted bioprosthetic valve designed to restore one-way blood flow in the deep veins of the leg.